Rupali Arora

1.5k total citations
30 papers, 358 citations indexed

About

Rupali Arora is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Rupali Arora has authored 30 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Obstetrics and Gynecology, 13 papers in Reproductive Medicine and 8 papers in Molecular Biology. Recurrent topics in Rupali Arora's work include Ovarian cancer diagnosis and treatment (13 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Uterine Myomas and Treatments (6 papers). Rupali Arora is often cited by papers focused on Ovarian cancer diagnosis and treatment (13 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Uterine Myomas and Treatments (6 papers). Rupali Arora collaborates with scholars based in United Kingdom, United States and Austria. Rupali Arora's co-authors include Martin Widschwendter, Usha Menon, Allison Jones, Louis Dubeau, D. Jurkovic, Daniel Reisel, Jacqueline McDermott, Miekel van de Sandt, David Jenkins and Wim Quint and has published in prestigious journals such as Nature Communications, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Rupali Arora

27 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rupali Arora United Kingdom 12 150 117 103 75 71 30 358
Narges Izadi‐Mood Iran 11 138 0.9× 72 0.6× 170 1.7× 112 1.5× 41 0.6× 40 405
Sima Kadkhodayan Iran 8 123 0.8× 71 0.6× 163 1.6× 69 0.9× 77 1.1× 19 314
Bent Fiane Norway 11 187 1.2× 103 0.9× 196 1.9× 101 1.3× 80 1.1× 14 494
Pamela Stone United States 11 95 0.6× 134 1.1× 93 0.9× 56 0.7× 49 0.7× 15 374
Richard Hadwin United Kingdom 7 89 0.6× 64 0.5× 83 0.8× 129 1.7× 46 0.6× 12 280
Tommaso Grassi Italy 12 266 1.8× 53 0.5× 231 2.2× 76 1.0× 93 1.3× 32 422
Anna Dańska-Bidzińska Poland 11 190 1.3× 68 0.6× 175 1.7× 99 1.3× 47 0.7× 42 405
Luis Z. Blanco United States 11 86 0.6× 69 0.6× 60 0.6× 35 0.5× 64 0.9× 32 358
Kellie S. Matthews United States 10 115 0.8× 50 0.4× 68 0.7× 38 0.5× 69 1.0× 17 328
Nathalie Reesink‐Peters Netherlands 13 70 0.5× 200 1.7× 134 1.3× 225 3.0× 95 1.3× 18 470

Countries citing papers authored by Rupali Arora

Since Specialization
Citations

This map shows the geographic impact of Rupali Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupali Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupali Arora more than expected).

Fields of papers citing papers by Rupali Arora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupali Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupali Arora. The network helps show where Rupali Arora may publish in the future.

Co-authorship network of co-authors of Rupali Arora

This figure shows the co-authorship network connecting the top 25 collaborators of Rupali Arora. A scholar is included among the top collaborators of Rupali Arora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupali Arora. Rupali Arora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Newton, Claire, Viola Liberale, Matthew Burnell, et al.. (2024). Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer. Journal of Obstetrics and Gynaecology. 44(1). 2344529–2344529. 1 indexed citations
2.
Barrett, James E., Chiara Herzog, Charlotte D. Vavourakis, et al.. (2024). High performance of the DNA methylation‐based WID‐qEC test for detecting uterine cancers independent of sampling modalities. International Journal of Cancer. 155(5). 800–806. 3 indexed citations
3.
Barrett, James E., Chiara Herzog, Rupali Arora, et al.. (2024). Performance of the WID‐qEC test to detect uterine cancers in black women with abnormal uterine bleeding: A prospective observational cohort study in Ghana. International Journal of Cancer. 156(5). 1055–1064. 1 indexed citations
4.
Chindera, Kantaraja, May Sabry, Nafisa Wilkinson, et al.. (2024). Natural Killer Cell Dysfunction in Premenopausal BRCA1 Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis. Cancers. 16(6). 1186–1186.
5.
Arora, Rupali, et al.. (2023). Molecular Testing in Ovarian Tumours: Challenges from the Pathologist’s Perspective. Diagnostics. 13(12). 2072–2072. 2 indexed citations
6.
Menon, Usha, Aleksandra Gentry‐Maharaj, Matthew Burnell, et al.. (2023). Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial. The Lancet Oncology. 24(9). 1018–1028. 24 indexed citations
7.
8.
Arora, Rupali, Daniel M. Berney, Constantine Alifrangis, et al.. (2023). Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy. Frontiers in Oncology. 13. 1271647–1271647. 2 indexed citations
9.
10.
Pashankar, Farzana, Krisztina Hanley, Michelle Lockley, et al.. (2022). Addressing the diagnostic and therapeutic dilemmas of ovarian immature teratoma: Report from a clinicopathologic consensus conference. European Journal of Cancer. 173. 59–70. 7 indexed citations
11.
Naftalin, J., et al.. (2020). Imaging in gynecological disease (21): clinical and ultrasound characteristics of accessory cavitated uterine malformations. Ultrasound in Obstetrics and Gynecology. 57(5). 821–828. 19 indexed citations
12.
Singh, Naveena, Michael S. Anglesio, Rupali Arora, et al.. (2017). Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage. International Journal of Gynecological Pathology. 37(4). 324–330. 9 indexed citations
13.
Bartlett, Thomas E., Kantaraja Chindera, Jacqueline McDermott, et al.. (2016). Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution. Nature Communications. 7(1). 11620–11620. 51 indexed citations
14.
Eminowicz, Gemma, Uzma Asghar, Amy A. Kirkwood, et al.. (2016). Uterine carcinosarcoma: a retrospective clinical cohort analysis. Annals of Oncology. 27. vi310–vi310. 1 indexed citations
15.
Griffin, Heather, Yasmina Soneji, Romy van Baars, et al.. (2015). Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM. Modern Pathology. 28(7). 977–993. 57 indexed citations
16.
17.
Freeman, Alex, et al.. (2011). PCR-based tissue identification: the UCLH experience. Journal of Clinical Pathology. 64(10). 921–923. 1 indexed citations
18.
Tirabosco, Roberto, Rupali Arora, Hongtao Ye, et al.. (2010). Primary Myxoid Liposarcoma of the Ovary in an Adolescent Girl: A Case Report. International Journal of Gynecological Pathology. 29(3). 256–259. 6 indexed citations
19.
Güth, Uwe, et al.. (2010). Total Vaginal Necrosis. International Journal of Gynecological Cancer. 20(1). 54–60. 12 indexed citations
20.
Widschwendter, Martin, Sophia Apostolidou, Allison Jones, et al.. (2009). HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: A proof of principle study. International Journal of Cancer. 125(9). 2214–2218. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Narges Izadi‐Mood Breakdown of academic impact, for papers by Sima Kadkhodayan Breakdown of academic impact, for papers by Bent Fiane Breakdown of academic impact, for papers by Pamela Stone Breakdown of academic impact, for papers by Richard Hadwin Breakdown of academic impact, for papers by Tommaso Grassi Breakdown of academic impact, for papers by Anna Dańska-Bidzińska Breakdown of academic impact, for papers by Luis Z. Blanco Breakdown of academic impact, for papers by Kellie S. Matthews Breakdown of academic impact, for papers by Nathalie Reesink‐Peters
Rankless by CCL
2026